1
Mar 19, 2024
The Way Forward for Decentralise Clinical Trials in Japan: As Decentralized clinical trials, brings participants the opportunity of participating in a clinical trial from the ease of their home or a local healthcare facility which is different to the traditional clinical trial site location far from the participant’s home. 3H, a Home-based clinical trial leader […]
2
Mar 25, 2022
Clinical trial conduct is a substantial investment requiring the right mix of resources and time. With the pharmaceutical industry facing many challenges in the Western world due to escalating costs and challenges in meeting the recruitment and retention of subjects, there is a trend in navigating clinical trial options in the Asian continent. Contract research […]
3
Dec 14, 2021
Supporting clinical trial patients at home is getting popular choice today in Japan following this pandemic. The need for decentralized clinical trials in Japan has increased, as measures have been implemented to prevent the re-emergence of the outbreak and streamline the systems used to run clinical trials. Unless mandatory, clinical trial patients are served in […]
4
Jul 1, 2021
South Korea has made a name in the clinical trial industry through its unprecedented growth in the industry during the past two decades. There has been several regulatory reforms, adoption of ICH-GCP and continuous investment by the government to enhance the standards and quality of clinical trial conduct to make the country a Global Centre […]
5
Jun 11, 2021
Medical care is undergoing rapid changes and the latest technology has provided solutions for the growing complex problems in aging care and other healthcare needs. With the pandemic taking a toll, it has added innovative care delivery methods for the nursing of patients from the comfort of homes moving beyond the traditional hospital beds where […]
6
Mar 22, 2021
The Covid-19 pandemic has brought in unique challenges to the clinical trial industry world over. Overall there have been substantial changes to healthcare access, health risks and daily interactions causing concern over the conduct of clinical trials during this period. The government bodies have greatly restricted the movement of public, by enacting laws to ensure […]